Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ImaCor is a medical technology company that specializes in advanced hemodynamic monitoring solutions for the critical care environment. The company is best known for developing the ClariTEE, the world's first and only miniaturized, disposable transesophageal echocardiography (TEE) probe designed for long-term monitoring of patients in the intensive care unit (ICU). Their proprietary Zura platform integrates this probe to provide clinicians with real-time, direct visualization of cardiac function, facilitating more accurate assessments of fluid responsiveness and ventricular performance. This technology aims to replace intermittent, indirect measurements with continuous data to improve decision-making for patients experiencing shock, sepsis, or recovering from cardiac surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ImaCor.